Back

Cumulative dose of iv furosemide as a predictor of in-hospital outcome among acute heart failure patients

19 May 2025 (11:00 - 11:45)
Organised by: Logo
Congress Presentation Part of: Acute heart failure treatment Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Fadel Bahouth

EMMS Nazareth Hospital, Nazareth (Israel)

6 More presentations in this session

Presentation thumbnail
Chloride repletion and diuretic response in patients with ambulatory worsening heart failure
Doctor J. Nunez Villota (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Early response to diuretics and prediction of outcomes in ambulatory worsening heart failure: natriuresis vs. diuresis
Miss M. Cobo Marcos (Majadahonda, ES)
Abstract Slides Video
Presentation thumbnail
Nurse-provided virtual care successfully manages the majority of heart failure patients with features of early clinical deterioration
Ms E. Brennan (Dublin, IE)
Abstract Slides Video
Presentation thumbnail
Home urinary sodium measurements as a predictor of heart failure stability after acute heart failure hospitalization
Doctor E. Meekers (Genk, BE)
Abstract Slides Video
Presentation thumbnail
The hidden threat of septic cardiomyopathy: unmasking its impact on ICU survival
Doctor J. Fernandes Pedro (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure treatment

The Event

Event poster

Heart Failure 2025

19 May 2025 11:00 CET
You may be interested in
thumbnail
Congress Presentation
What is the prognostic significance of initial dose of iv diuretics in acute heart failure?
thumbnail
Congress Presentation
Impact of initial furosemide dosing on hospitalization and 1-year mortality in acute heart failure
thumbnail
Congress Presentation
Thoracic fluid content as a marker of high intravenous diuretic requirements in patients hospitalized for heart failure decompensation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources